The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1245-1254

  Liao, Siyun ^a   Bodmer, Janet R ^a   Azhar, Mohamad ^a,b   Newman, Gilbert ^a   Coffin, J Douglas ^c   Doetschman, Thomas ^a,b   Schultz, Jo El J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF MONTANA   (United States)

Author keywords

Cardioprotection; Fibroblast growth factor; Fibroblast growth factor receptor; Human or mouse FGF; Ischemia reperfusion injury; Low or high molecular weight isoforms

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; CREATINE KINASE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; GENE OVEREXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REPERFUSION INJURY; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CREATINE KINASE; FIBROBLAST GROWTH FACTOR 2; HEART; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR WEIGHT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; REPERFUSION INJURY;

MURINAE;

EID: 77952675539     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.01.014     Document Type: Article

References (45)

1. Okada-Ban M., Thiery J.P., Jouanneau J. Fibroblast growth factor-2. Int. J. Biochem. Cell. Biol. 2000, 32(3):263-267.
2. Doble B.W., Fandrich R.R., Liu L., Padua R.R., Kardami E. Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases. Biochem. Biophys. Res. Commun. 1990, 173(3):1116-1122.
3. Dono R., Zeller R. Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis. Dev. Biol. 1994, 163(2):316-330.
4. Powell P.P., Klagsbrun M. Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. J. Cell. Physiol. 1991, 148(2):202-210.
5. Sommer A., Brewer M.T., Thompson R.C., Moscatelli D., Presta M., Rifkin D.B. A form of human basic fibroblast growth factor with an extended amino terminus. Biochem. Biophys. Res. Commun. 1987, 144(2):543-550.
6. Okada-Ban M., Moens G., Thiery J.P., Jouanneau J. Nuclear 24 kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells. Oncogene 1999, 18(48):6719-6724.
7. Sun G., Doble B.W., Sun J.M., Fandrich R.R., Florkiewicz R., Kirshenbaum L., et al. CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J. Cell. Physiol. 2001, 186(3):457-467.
8. Claus P., Doring F., Gringel S., Muller-Ostermeyer F., Fuhlrott J., Kraft T., et al. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J. Biol. Chem. 2003, 278(1):479-485.
9. Taverna S., Ghersi G., Ginestra A., Rigogliuso S., Pecorella S., Alaimo G., et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J. Biol. Chem. 2003, 278(51):51911-51919.
10. Pasumarthi K.B., Kardami E., Cattini P.A. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ. Res. 1996, 78(1):126-136.
11. Detillieux K.A., Sheikh F., Kardami E., Cattini P.A. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc. Res. 2003, 57(1):8-19.
12. House S.L., Bolte C., Zhou M., Doetschman T., Klevitsky R., Newman G., et al. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 2003, 108(25):3140-3148.
13. Liao S., Porter D., Scott A., Newman G., Doetschman T., Schultz Jel J. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. J. Mol. Cell. Cardiol. 2007, 42(1):106-120.
14. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 2000, 7(3):165-197.
15. Hughes S.E. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J. Histochem. Cytochem. 1997, 45(7):1005-1019.
16. Cool S.M., Sayer R.E., van Heumen W.R., Pickles J.O., Nurcombe V. Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochem. J. 2002, 34(6-7):291-297.
17. Mima T., Ueno H., Fischman D.A., Williams L.T., Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(2):467-471.
18. Liu L., Pasumarthi K.B., Padua R.R., Massaeli H., Fandrich R.R., Pierce G.N., et al. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am. J. Physiol. 1995, 268(5 Pt 2):H1927-H1938.
19. Jiang Z.S., Padua R.R., Ju H., Doble B.W., Jin Y., Hao J., et al. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am. J. Physiol. Heart Circ. Physiol. 2002, 282(3):H1071-H1080.
20. Muinck E.D., Nagy N., Tirziu D., Murakami M., Gurusamy N., Goswami S.K., et al. Protection against myocardial ischemia-reperfusion injury by the angiogenic Masterswitch protein PR 39 gene therapy: the roles of HIF1alpha stabilization and FGFR1 signaling. Antioxid. Redox. Signal. 2007, 9(4):437-445.
21. Fujisawa H., Koide N., Kono T., Takayama K., Tsukioka K., Wada Y., et al. Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma. J. Cardiovasc. Surg. (Torino) 2002, 43(5):589-594.
22. Pennisi D.J., Ballard V.L., Mikawa T. Epicardium is required for the full rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. Dev. Dyn. 2003, 228(2):161-172.
23. Davis M.G., Zhou M., Ali S., Coffin J.D., Doetschman T., Dorn G.W. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J. Mol. Cell. Cardiol. 1997, 29(4):1061-1072.
24. Azhar M., Yin M., Zhou M., Li H., Mustafa M., Nusayr E., et al. Gene targeted ablation of high molecular weight fibroblast growth factor-2. Dev. Dyn. 2009, 238(2):351-357.
25. Mohammadi M., Froum S., Hamby J.M., Schroeder M.C., Panek R.L., Lu G.H., et al. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998, 17(20):5896-5904.
26. Fishbein M.C., Meerbaum S., Rit J., Lando U., Kanmatsuse K., Mercier J.C., et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am. Heart J. 1981, 101(5):593-600.
27. Fryer R.M., Patel H.H., Hsu A.K., Gross G.J. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(3):H1184-H1192.
28. Gualandris A., Arese M., Shen B., Rifkin D.B. Modulation of cell growth and transformation by doxycycline-regulated FGF-2 expression in NIH-3T3 cells. J. Cell. Physiol. 1999, 181(2):273-284.
29. Bao W.G.Y., Tang X., Wu W., Bolli R. Variability in susceptibility to ischemia among different strains of mice. J. Mol. Cell. Cardiol. 2000, 32(5):A21.
30. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 2000, 468(1):6-10.
31. Pintucci G., Yu P.J., Saponara F., Kadian-Dodov D.L., Galloway A.C., Mignatti P. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. J. Cell. Biochem. 2005, 95(6):1292-1300.
32. Quarto N., Fong K.D., Longaker M.T. Gene profiling of cells expressing different FGF-2 forms. Gene 2005, 356:49-68.
33. Jiang Z.S., Jeyaraman M., Wen G.B., Fandrich R.R., Dixon I.M., Cattini P.A., et al. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J. Mol. Cell. Cardiol. 2007, 42(1):222-233.
34. Jiang Z.S., Wen G.B., Tang Z.H., Srisakuldee W., Fandrich R.R., Kardami E. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of the protein kinase C isoforms Akt and p70 S6 kinase. Can. J. Physiol. Pharmacol. 2009, 87(10):798-804.
35. Kardami E., Jiang Z.S., Jimenez S.K., Hirst C.J., Sheikh F., Zahradka P., et al. Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc. Res. 2004, 63(3):458-466.
36. Sheikh F., Sontag D.P., Fandrich R.R., Kardami E., Cattini P.A. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 280(3):H1039-H1050.
37. Thomas-Mudge R.J., Okada-Ban M., Vandenbroucke F., Vincent-Salomon A., Girault J.M., Thiery J.P., et al. Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases. Oncogene 2004, 23(27):4771-4779.
38. Cohen M.V., Yang X.M., Downey J.M. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am. J. Physiol. 1999, 277(5 Pt 2):H1754-H1761.
39. Gaubert F., Escaffit F., Bertrand C., Korc M., Pradayrol L., Clemente F., et al. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. J. Biol. Chem. 2001, 276(2):1545-1554.
40. Hortala M., Estival A., Pradayrol L., Susini C., Clemente F. Identification of c-Jun as a critical mediator for the intracrine 24kDa FGF-2 isoform-induced cell proliferation. Int. J. Cancer 2005, 114(6):863-869.
41. Bouche G., Baldin V., Belenguer P., Prats H., Amalric F. Activation of rDNA transcription by FGF-2: key role of protein kinase CKII. Cell. Mol. Biol. Res. 1994, 40(5-6):547-554.
42. Florkiewicz R.Z., Baird A., Gonzalez A.M. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 1991, 4(4):265-275.
43. Bugler B., Amalric F., Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 1991, 11(1):573-577.
44. Piotrowicz R.S., Martin J.L., Dillman W.H., Levin E.G. The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J. Biol. Chem. 1997, 272(11):7042-7047.
45. Yu P.J., Ferrari G., Galloway A.C., Mignatti P., Pintucci G. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J. Cell. Biochem. 2007, 100(5):1100-1108.